University Hospital of Montpellier
Montpellier, 34295, France
NCT Number: NCT02844231
Sleepwalking (also called somnambulism) is a disorder in which only SWS is disrupted. This NREM parasomnia is characterized by inappropriate motor behaviors, usually initiated during arousal from SWS, that induce psychological distress and alter quality of life, leading to fatigue, excessive daytime sleepiness, and objectively impaired vigilance in the morning.
The pathophysiology of sleepwalking remains poorly understood. Sleepwalkers had difficulty maintaining stable, consolidated sleep and experienced more arousals and microarousals, specifically from SWS, leading to increased NREM instability, especially during the first sleep cycles. The brain is partially awake, resulting in behavioral manifestations, and partially in NREM sleep, resulting in no conscious awareness of actions.
A Single Photonic Emission Computed Tomography (SPECT) study of one sleepwalking episode found increased activation in the posterior cingulate cortex and cerebellum, with deactivation in the frontoparietal associative cortices. Data from intracerebral EEGs during confusional arousals confirmed both local arousal of the motor and cingulate cortices and increased delta activity in the frontoparietal associative cortices.
The investigators thus proposed a controlled study of SPECT imagery in 24 sleepwalkers (12 SPECT during a SW episode and 12 SPECT during slow wave sleep and 24 during wakefulness) and 12 controls (during slow wave sleep and wakefulness). SW episodes will be elicited by sleep deprivation condition associated with forced arousal (auditory stimulus).
The comparative analyses of SPECT acquisitions between different states (wakefulness, slow wave sleep and SW) and populations (sleepwalkers versus controls) will provide new insights about the complex pathophysiology of SW episodes.
Looking for future studies?
Notify Me18 year–39 year
All sexes
Interventional
Not applicable
Montpellier, 34295, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
PATIENTS
Inclusion criteria
Exclusion criteria
CONTROL GROUP
Inclusion criteria
Exclusion criteria
Time frame: Day 0
Time frame: Day 0
University Hospital, Montpellier
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02648568
Mental Disorders, Nervous System Diseases
Paris, France
View Trial DetailsNCT07361315
Confusional Arousal, Mental Disorders
Winnipeg, Manitoba, Canada
View Trial DetailsNCT05321355
Apnea, Disorders of Excessive Somnolence
Mainz, Rhineland-Palatinate, Germany
View Trial DetailsNCT03018912
Apnea, Chronobiology Disorders
Fontana, California, United States
View Trial Details